These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1953506)

  • 1. High density lipoproteins and coronary heart disease.
    Barter PJ
    Aust N Z J Med; 1991 Jun; 21(3):299-301. PubMed ID: 1953506
    [No Abstract]   [Full Text] [Related]  

  • 2. New diagnostic tests for assessing coronary heart disease risk.
    Naito HK
    Prog Clin Biol Res; 1988; 255():49-62. PubMed ID: 3277204
    [No Abstract]   [Full Text] [Related]  

  • 3. [High density lipoprotein prevents coronary heart disease].
    Johansson J; Mölgaard J
    Lakartidningen; 1991 Jun; 88(26-27):2386-9. PubMed ID: 1857163
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of low-density lipoprotein particle size and ratio of different lipoproteins and apolipoproteins with coronary heart disease.
    Biswas S; Ghoshal PK; Mandal SC; Mandal N
    J Cardiol; 2008 Oct; 52(2):118-26. PubMed ID: 18922385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of serum lipids, lipoproteins, and apolipoproteins with coronary artery disease assessed by coronary arteriography.
    Naito HK
    Ann N Y Acad Sci; 1985; 454():230-8. PubMed ID: 3865610
    [No Abstract]   [Full Text] [Related]  

  • 6. Apolipoproteins and coronary heart disease.
    Schaefer EJ
    Eur J Clin Invest; 1994 Jul; 24(7):441-3. PubMed ID: 7957499
    [No Abstract]   [Full Text] [Related]  

  • 7. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
    Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K
    Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apolipoproteins in atherosclerosis].
    Carino C; Rauseo R; Tiboni GM; De Martiis M
    Clin Ter; 1984 Sep; 110(5):477-82. PubMed ID: 6238762
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid and lipoprotein fractions and coronary artery disease.
    Lavie CJ
    Mayo Clin Proc; 1993 Jun; 68(6):618-9. PubMed ID: 8497140
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipoprotein measurements--setting priorities.
    Wilson PW
    Am J Med; 2001 Jan; 110(1):71-2. PubMed ID: 11152872
    [No Abstract]   [Full Text] [Related]  

  • 11. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis.
    Miller NE
    Am Heart J; 1987 Feb; 113(2 Pt 2):589-97. PubMed ID: 3544775
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma lipids, HDL and apolipoproteins, and coronary heart disease in men less than 50 years old. A case-control study.
    Cubero GI; Reguero JJ; Batalla A; Simarro E; Posada IS; Braga S; Negrete JL
    Acta Cardiol; 1998; 53(5):269-73. PubMed ID: 9922804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.
    Phillips NR; Waters D; Havel RJ
    Circulation; 1993 Dec; 88(6):2762-70. PubMed ID: 8252689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in coronary artery disease risk-factor research: what remains to be done?
    Crouse JR
    Clin Chem; 1984 Jul; 30(7):1125-7. PubMed ID: 6428775
    [No Abstract]   [Full Text] [Related]  

  • 15. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
    Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G
    J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease.
    Stuyt PM; Brenninkmeijer BJ; Demacker PN; Hendriks JC; van Elteren P; Stalenhoef AF; van 't Laar A
    Scand J Clin Lab Invest; 1991 Sep; 51(5):425-35. PubMed ID: 1947727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis.
    Schmidt SB; Wasserman AG; Muesing RA; Schlesselman SE; Larosa JC; Ross AM
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1459-62. PubMed ID: 3923814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of children and coronary heart disease patients with low high density lipoprotein cholesterol levels.
    Ohta T; Saku K; Nakamura R; Maung KK; Matsuda I
    Atherosclerosis; 1998 Apr; 137(2):321-8. PubMed ID: 9622275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries.
    Tan MH; Weldon KL; Albers JJ; Cheung MC; Havel RJ; Vigne JL
    Clin Invest Med; 1980; 3(3-4):225-32. PubMed ID: 6784991
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma lipoproteins and coronary heart disease.
    Scanu AM
    Ann Clin Lab Sci; 1978; 8(2):79-83. PubMed ID: 205164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.